Armata Pharmaceuticals (ARMP) Operating Margin (2013 - 2020)
Armata Pharmaceuticals' (ARMP) quarterly Operating Margin came in at 14806.45% in Q2 2020, down 25.21% quarter-over-quarter from 11825.0% in Q4 2017.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) Operating Margin (2013 - 2020) Analysis & Trends
Armata Pharmaceuticals has disclosed Operating Margin across 6 years of filings, most recently posting 14806.45% for Q2 2020.
- In Q2 2020, Operating Margin changed N/A year-over-year to 14806.45%; the TTM figure through Jun 2020 stood at 17661.54% (changed N/A YoY), while the FY2017 annual figure was 14048.7%, down 505716.0% from the prior year.
- Operating Margin came in at 14806.45% for Q2 2020 at Armata Pharmaceuticals, down from 11825.0% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 1963.16% in Q3 2017 to a low of 53927.27% in Q4 2016.
- Average Operating Margin over 3 years is 16465.83%, with a median of 11748.28% recorded in 2016.
- Year-over-year, Operating Margin tumbled 5163040 bps in 2016 and soared 4210227 bps in 2017.
- Over 3 years, Operating Margin stood at 53927.27% in 2016, then jumped by 78 bps to 11825.0% in 2017, then slipped by 25 bps to 14806.45% in 2020.
- Per Business Quant data, the three most recent Operating Margin figures were 14806.45% in Q2 2020, 11825.0% in Q4 2017, and 1963.16% in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -25,380.93% |
| 10 | Armata Pharmaceuticals | 203.22 Mn | 179.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,697.90% |
| Jun 30, 2015 | -2,541.18% |
| Mar 31, 2015 | -2,222.55% |
| Dec 31, 2014 | -2,571.29% |
| Sep 30, 2014 | -5,078.64% |
| Jun 30, 2014 | -3,710.89% |
| Mar 31, 2014 | -2,436.54% |
| Dec 31, 2013 | 1,026.19% |
| Sep 30, 2013 | -78,033.33% |
| Jun 30, 2013 | -1,950.32% |